624 related articles for article (PubMed ID: 17380266)
1. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.
Bhumkar DR; Joshi HM; Sastry M; Pokharkar VB
Pharm Res; 2007 Aug; 24(8):1415-26. PubMed ID: 17380266
[TBL] [Abstract][Full Text] [Related]
2. Gold nanoparticles as carriers for efficient transmucosal insulin delivery.
Joshi HM; Bhumkar DR; Joshi K; Pokharkar V; Sastry M
Langmuir; 2006 Jan; 22(1):300-5. PubMed ID: 16378435
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
4. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
6. Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment.
Mumuni MA; Kenechukwu FC; Ofokansi KC; Attama AA; Díaz DD
Carbohydr Polym; 2020 Feb; 229():115506. PubMed ID: 31826394
[TBL] [Abstract][Full Text] [Related]
7. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.
Barbari GR; Dorkoosh F; Amini M; Bahari Javan N; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M
Int J Nanomedicine; 2018; 13():5127-5138. PubMed ID: 30233176
[TBL] [Abstract][Full Text] [Related]
9. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA
Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421
[TBL] [Abstract][Full Text] [Related]
10. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of insulin chitosan-nanoparticles loaded in buccal films.
Al-Nemrawi NK; Alsharif SSM; Alzoubi KH; Alkhatib RQ
Pharm Dev Technol; 2019 Oct; 24(8):967-974. PubMed ID: 31092092
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
14. Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model.
Mukhopadhyay P; Sarkar K; Chakraborty M; Bhattacharya S; Mishra R; Kundu PP
Mater Sci Eng C Mater Biol Appl; 2013 Jan; 33(1):376-82. PubMed ID: 25428084
[TBL] [Abstract][Full Text] [Related]
15. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
Urimi D; Agrawal AK; Kushwah V; Jain S
AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
[TBL] [Abstract][Full Text] [Related]
16. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
17. Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system.
Al-Remawi M; Elsayed A; Maghrabi I; Hamaidi M; Jaber N
Pharm Dev Technol; 2017 May; 22(3):390-398. PubMed ID: 27470482
[TBL] [Abstract][Full Text] [Related]
18. Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery.
Reis CP; Ribeiro AJ; Veiga F; Neufeld RJ; Damgé C
Drug Deliv; 2008 Feb; 15(2):127-39. PubMed ID: 18293199
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-reduced gold nanoparticles: a novel carrier for the preparation of spray-dried liposomes for topical delivery.
Padamwar MN; Patole MS; Pokharkar VB
J Liposome Res; 2011 Dec; 21(4):324-32. PubMed ID: 21623705
[TBL] [Abstract][Full Text] [Related]
20. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.
Momoh MA; Kenechukwu FC; Nnamani PO; Umetiti JC
Drug Deliv; 2015; 22(6):837-48. PubMed ID: 24670092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
